YOU CAN APPLY IF YOU:

​​

• Are between 18 and 70 years old.

• Have had with signs and symptoms of hidradenitis suppurativa for at least 1 year.

• Have HS lesions in at least 2 different areas on your body, one of which must be Hurley Stage II or III.

• Have had an inadequate response for treatment of HS.

• Have 20 or fewer draining tunnels/fistulas.

• Have tried in the past no more than one anti-TNF therapy for at least 12 weeks.​​

 

YOU CAN'T APPLY IF YOU:

​

• Have any active or chronic infection requiring systemic treatment.

• Have inflammatory conditions, other than HS (including, but not limited to, systemic lupus, sclerosis, myositis, rheumatoid arthritis, IBD, MS, sarcoidosis, etc.).

• Are pregnant, breastfeeding, or plan on becoming pregnant during the treatment period.

• There may be other information that the doctor will use to decide if you’re eligible to join; the above are the main study criteria.

 

HOW IT WORKS:

 

The study will last approximately 36 weeks minimum, which includes:

 

• up to 4 weeks to allow the study doctor to assess eligibility with 1 visit to the site (with a blood sample).

​

• up to 16 weeks for treatment with study drug or placebo which includes 5 visits to the clinical site.

​

• Blood samples will be taken at each visit.

​

• and up to 16 weeks for safety follow-up with 1 visit to the site (including a blood sample).

 

• You will have close monitoring including physical examination to evaluate the efficacy of the investigational study drug and blood assessments to evaluate the safety of the investigational study drug.

 

• You may additionally enroll in an approximately 20 months optional treatment period after the main study, during which you will receive the active drug once a month at the clinical site or at home.

 

• Blood samples will be taken 3 times over the extension of the study.​​

 

HERE'S WHAT'S REQUIRED OF YOU:

 

• You must be willing to have an exam and injection every 4 weeks

• You must be willing to attend ALL study visits during the trial.

• You will have multiple forms that have to be completed (# of forms vary per visit) which may be of a sensitive nature and ask about the impact of your HS on your life.

• You will be required to complete a daily diary.

• You will not be allowed to take any opioids during the study (NSAIDs, acetaminophen, and tramadol are OK).

​

​

If you met the criteria above and are interested in learning more or enrolling, click HERE!

​

 OR VISIT SANOFISTUDIES.COM KEYWORDS: ACT17967

 

Intended for U.S. Audiences Only © 2024 Sanofi US Services, Inc. All Rights Reserved.The investigational study drug is not approved by health authorities such as the US Food and Drug Administration (FDA) and is still under investigation for the treatment of hidradenitis suppurativa, so its effectiveness and safety have not been established.